{
    "nct_id": "NCT04722341",
    "official_title": "Time-Restricted Eating and Cancer: Clinical Outcomes, Mechanisms, and Moderators",
    "inclusion_criteria": "* Any sex/gender of any ethnic/racial background\n* Age greater than or equal to 18 years\n* Histologically confirmed rectal cancer stage II, III, or IV (if curative) per AJCC criteria\n* Histologically confirmed HER2+ or triple negative breast cancer stage I, II, III, or IV (only if definitive intent) per AJCC criteria\n* BMI 18.5 kg/m2 or greater\n* Will receive neoadjuvant therapy\n* Has completed ≤ 4 weeks of neoadjuvant treatment prior to study enrollment\n* Willing and able to adhere to the assessments, visit schedules, prohibitions, and restrictions\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* History of cytotoxic chemotherapy less than or equal to 12 months prior to rectal or breast cancer diagnosis\n* Allergic reaction to any of the treatment agents\n* Any prior pelvic radiotherapy\n* Currently active second malignancy other than non-melanoma skin cancers or cervical carcinoma in situ\n* History of GI perforation ≤12 months prior to enrollment\n* History of predisposing colonic or small bowel disorders with severe or rapidly worsening symptoms (not related to current cancer symptoms)\n* Receiving any parenteral nutrition or enteral (tube) feeding or using similar nutritional supplement during the study period\n* History of uncontrolled CHF defined as NYHA Class III or greater\n* Pre-existing grade ≥3 neuropathy\n* Currently participating in or has participated in a study of an investigational agent or investigational device ≤4 weeks of the first dose of treatment\n* Pregnant or breastfeeding\n* Currently perform overnight shift work more than one day/week on average\n* Strictly adhering to a <10-hour eating window on most days\n* Known psychiatric or substance abuse disorders that would interfere with adhering to the requirements of the trial",
    "miscellaneous_criteria": ""
}